Recent findings might help ease concerns for women suffering with lupus and interested in having a child. New research concluded that most women diagnosed with lupus…
Isaura Santos
Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Isaura Santos
Susan Manzi, Chair of the Department of Medicine at Allegheny Health Network, was recently presented with…
Actelion recently announced its commitment to accelerate clinical development efforts concerning immunological disorders following a broad medical, scientific and commercial assessment of a series…
Anthera Pharmaceuticals, Inc. announced the completion of its Phase 3 trial (CHABLIS-SC1), which evaluated the effect of …
UBM Medica US, a company that delivers integrated and strategic communications solutions, recently announced that Rheumatology…
ImmuPharma PLC and Simbec-Orion Group Limited recently announced a collaboration agreement for the execution of a Pivotal Phase III clinical…
Researchers from St. Jude Children’s Research Hospital found that a protein involved in tumor formation suppression also plays a…
23andMe, Inc., a personal genetics company that helps people better understand and benefit from the human genome, recently announced a new partnership with …
A national leader in lupus research and chief of Rheumatology at the Beth Israel Deaconess Medical Center (BIDMC)Â George…
The Kadmon Corporation’s Phase 2 oral drug, KD025, a potent, bio-available and highly selective inhibitor of ROCK2 (Rho-associated coiled-coiled kinase 2) that…